The 7th Eurasia Congress of Infectious Diseases (EACID), Tiflis, Georgia, 30 September - 03 October 2015, pp.97
Most common early diagnostic tool of IFI in high risk Hematology patients is galactomannan (GM) test. False positivity has been
observed with TZP and other antibiotics. Widely usage of generic drugs has been continued owing to a significant cost advantage
over original brand.
The aim of this study is to compare the interaction of original and generic TZP formulations in terms of galactomannan test positivity.
In January- February period, GM index was negative for all 35 patients who were receiving TZP. In that period, original TZP was used
for patients in our institute.
On the other hand, of 50 patients who were receiving TZP, GM index of 46 (92%) was above 0.5 in May. In that month, one type
generic TZP was used for patients in our institute. Of the patients, 33 was male (66%), 27 were relapse diseases, 14 were new
diagnosis, and 9 were on remission. Allogeneic hematopoietic stem cell transplantation was performed in 9 and autologous HSCT
in 12 patients. Fifteen patients were not neutropenic on GM test time. Thirty patients were receiving an antifungal agent which
was including posaconazol in 10, fluconazole in 10, voriconazole in 8, and caspofungin in 2 patients pre GM test. In 13 (31.7%) of
41 patients performed computed tomography (CT) scan, invasive fungal infection was supported by CT scan image. Moreover, the
rate of CT scan was more frequent (87% vs. 25%) in GM positive patients than those GM negative (p=0.016). This may lead more
unnecessary expenses of time and money. Mean GM positivity duration after beginning of TZP was 2.98±1.6 day, and mean GM
negativity time after discontinuation of TZP was 4.62±3.1 day.
It was performed an analysis on GM levels of two generic and one original TZP. One of generic formulation had high GM levels
In conclusion, generic formulations of drugs are used in developing countries, but it should be cautious about unexpected
interactions. High rate GM test positivity caused by generic formulation of TZP may lead unexpected high cost such as CT scan,
maybe unnecessary antifungal treatment